Title |
Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women
|
---|---|
Published in |
JNCI: Journal of the National Cancer Institute, January 2018
|
DOI | 10.1093/jnci/djx265 |
Pubmed ID | |
Authors |
Ranjit Manchanda, Shreeya Patel, Vladimir S Gordeev, Antonis C Antoniou, Shantel Smith, Andrew Lee, John L Hopper, Robert J MacInnis, Clare Turnbull, Susan J Ramus, Simon A Gayther, Paul D P Pharoah, Usha Menon, Ian Jacobs, Rosa Legood |
X Demographics
The data shown below were collected from the profiles of 84 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 23 | 27% |
United Kingdom | 9 | 11% |
Italy | 3 | 4% |
Netherlands | 3 | 4% |
Belgium | 2 | 2% |
France | 2 | 2% |
Thailand | 1 | 1% |
Australia | 1 | 1% |
Brazil | 1 | 1% |
Other | 8 | 10% |
Unknown | 31 | 37% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 53 | 63% |
Scientists | 20 | 24% |
Practitioners (doctors, other healthcare professionals) | 8 | 10% |
Science communicators (journalists, bloggers, editors) | 3 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 192 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 192 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 30 | 16% |
Other | 22 | 11% |
Student > Ph. D. Student | 17 | 9% |
Student > Master | 15 | 8% |
Student > Bachelor | 11 | 6% |
Other | 32 | 17% |
Unknown | 65 | 34% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 51 | 27% |
Biochemistry, Genetics and Molecular Biology | 30 | 16% |
Nursing and Health Professions | 6 | 3% |
Economics, Econometrics and Finance | 6 | 3% |
Agricultural and Biological Sciences | 5 | 3% |
Other | 21 | 11% |
Unknown | 73 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 196. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 January 2022.
All research outputs
#205,656
of 26,017,215 outputs
Outputs from JNCI: Journal of the National Cancer Institute
#139
of 7,934 outputs
Outputs of similar age
#4,713
of 457,878 outputs
Outputs of similar age from JNCI: Journal of the National Cancer Institute
#4
of 59 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,934 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.4. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 457,878 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 59 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.